Year in Review: Medlab (ASX:MDC) with Chief Executive Officer, Dr Sean Hall
Stockhead’s Year in Review video series is a yearly wrap up address from company leaders showcasing latest achievements, discoveries and developments of emerging ASX companies.
In this instalment Dr Sean Hall, Chief Executive Officer at Medlab (ASX:MDC), takes a look back on the company’s achievements in 2022.
Medlab is an Australian biotechnology company, focused on the delivery of medicinal solutions and hope for patients with unmet needs. Medlab is developing therapeutics using its proprietary, next-generation delivery platform, NanoCelle®.
To hear about the company’s 2022 highlights, click above.